Abstract
Addressing the growing concern stemming from the issue of access to and affordability of drugs, this article argues for the use of a direct price control mechanism to prevent the abuse of monopoly rights emerging from the patenting of pharmaceutical products. The article also demonstrates the limited utility of compulsory licensing in achieving access to medicines, and explodes the myth of direct price control necessarily hindering innovation, consequently putting forward a persuasive case for reformulating and rigorously implementing India's hitherto impotent price control regime.
Recommended Citation
Prasad, Ajay and Iyengar, Varsha
(2008)
"Direct Price Control on Patented Drugs in India: The Probable Effects on Innovations and Access to Medicines,"
National Law School of India Review: Vol. 20:
Iss.
2, Article 8.
Available at:
https://repository.nls.ac.in/nlsir/vol20/iss2/8
